Logo image of CXW

CORECIVIC INC (CXW) Stock Fundamental Analysis

USA - NYSE:CXW - US21871N1019 - Common Stock

20.67 USD
+0.04 (+0.19%)
Last: 9/17/2025, 8:04:00 PM
20.67 USD
0 (0%)
After Hours: 9/17/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CXW. CXW was compared to 84 industry peers in the Commercial Services & Supplies industry. CXW has an average financial health and profitability rating. CXW has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CXW had positive earnings in the past year.
In the past year CXW had a positive cash flow from operations.
Of the past 5 years CXW 4 years were profitable.
CXW had a positive operating cash flow in each of the past 5 years.
CXW Yearly Net Income VS EBIT VS OCF VS FCFCXW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

CXW's Return On Assets of 3.39% is fine compared to the rest of the industry. CXW outperforms 65.48% of its industry peers.
The Return On Equity of CXW (7.04%) is better than 61.90% of its industry peers.
The Return On Invested Capital of CXW (5.45%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CXW is significantly below the industry average of 10.60%.
The last Return On Invested Capital (5.45%) for CXW is above the 3 year average (4.72%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.39%
ROE 7.04%
ROIC 5.45%
ROA(3y)2.77%
ROA(5y)1.65%
ROE(3y)5.91%
ROE(5y)3.57%
ROIC(3y)4.72%
ROIC(5y)4.97%
CXW Yearly ROA, ROE, ROICCXW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

The Profit Margin of CXW (5.21%) is better than 66.67% of its industry peers.
CXW's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 10.39%, CXW is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
In the last couple of years the Operating Margin of CXW has declined.
CXW has a Gross Margin of 24.70%. This is in the lower half of the industry: CXW underperforms 63.10% of its industry peers.
In the last couple of years the Gross Margin of CXW has declined.
Industry RankSector Rank
OM 10.39%
PM (TTM) 5.21%
GM 24.7%
OM growth 3Y-11.18%
OM growth 5Y-7.87%
PM growth 3YN/A
PM growth 5Y-18.12%
GM growth 3Y-5.42%
GM growth 5Y-3.25%
CXW Yearly Profit, Operating, Gross MarginsCXW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CXW is destroying value.
Compared to 1 year ago, CXW has less shares outstanding
The number of shares outstanding for CXW has been reduced compared to 5 years ago.
Compared to 1 year ago, CXW has an improved debt to assets ratio.
CXW Yearly Shares OutstandingCXW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CXW Yearly Total Debt VS Total AssetsCXW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.70, we must say that CXW is in the distress zone and has some risk of bankruptcy.
CXW has a Altman-Z score of 1.70. This is comparable to the rest of the industry: CXW outperforms 41.67% of its industry peers.
The Debt to FCF ratio of CXW is 5.98, which is a neutral value as it means it would take CXW, 5.98 years of fcf income to pay off all of its debts.
CXW's Debt to FCF ratio of 5.98 is fine compared to the rest of the industry. CXW outperforms 65.48% of its industry peers.
A Debt/Equity ratio of 0.68 indicates that CXW is somewhat dependend on debt financing.
CXW has a Debt to Equity ratio (0.68) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 5.98
Altman-Z 1.7
ROIC/WACC0.65
WACC8.36%
CXW Yearly LT Debt VS Equity VS FCFCXW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CXW has a Current Ratio of 1.60. This is a normal value and indicates that CXW is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.60, CXW is in line with its industry, outperforming 57.14% of the companies in the same industry.
CXW has a Quick Ratio of 1.60. This is a normal value and indicates that CXW is financially healthy and should not expect problems in meeting its short term obligations.
CXW's Quick ratio of 1.60 is fine compared to the rest of the industry. CXW outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
CXW Yearly Current Assets VS Current LiabilitesCXW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.33% over the past year.
Measured over the past years, CXW shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.17% on average per year.
Looking at the last year, CXW shows a small growth in Revenue. The Revenue has grown by 1.62% in the last year.
CXW shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.19% yearly.
EPS 1Y (TTM)58.33%
EPS 3Y25.31%
EPS 5Y-17.17%
EPS Q2Q%111.76%
Revenue 1Y (TTM)1.62%
Revenue growth 3Y1.74%
Revenue growth 5Y-0.19%
Sales Q2Q%9.81%

3.2 Future

The Earnings Per Share is expected to grow by 60.82% on average over the next years. This is a very strong growth
CXW is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.41% yearly.
EPS Next Y92.07%
EPS Next 2Y60.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9%
Revenue Next 2Y10.41%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXW Yearly Revenue VS EstimatesCXW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CXW Yearly EPS VS EstimatesCXW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.76, which indicates a rather expensive current valuation of CXW.
Compared to the rest of the industry, the Price/Earnings ratio of CXW indicates a somewhat cheap valuation: CXW is cheaper than 67.86% of the companies listed in the same industry.
CXW's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.20.
CXW is valuated correctly with a Price/Forward Earnings ratio of 13.10.
78.57% of the companies in the same industry are more expensive than CXW, based on the Price/Forward Earnings ratio.
CXW is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.76
Fwd PE 13.1
CXW Price Earnings VS Forward Price EarningsCXW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CXW is valued a bit cheaper than the industry average as 72.62% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CXW indicates a rather cheap valuation: CXW is cheaper than 82.14% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.96
EV/EBITDA 9.31
CXW Per share dataCXW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CXW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CXW's earnings are expected to grow with 60.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y60.82%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CXW!.
Industry RankSector Rank
Dividend Yield N/A

CORECIVIC INC

NYSE:CXW (9/17/2025, 8:04:00 PM)

After market: 20.67 0 (0%)

20.67

+0.04 (+0.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04
Inst Owners89.21%
Inst Owner Change-1.21%
Ins Owners1.91%
Ins Owner Change-4.51%
Market Cap2.21B
Analysts82.22
Price Target31.54 (52.59%)
Short Float %2.34%
Short Ratio2.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-76.74%
DP0.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)81.38%
Min EPS beat(2)78.22%
Max EPS beat(2)84.54%
EPS beat(4)4
Avg EPS beat(4)86.21%
Min EPS beat(4)68.32%
Max EPS beat(4)113.77%
EPS beat(8)6
Avg EPS beat(8)43.4%
EPS beat(12)9
Avg EPS beat(12)30.73%
EPS beat(16)10
Avg EPS beat(16)21.5%
Revenue beat(2)2
Avg Revenue beat(2)3.98%
Min Revenue beat(2)1.11%
Max Revenue beat(2)6.86%
Revenue beat(4)4
Avg Revenue beat(4)3.39%
Min Revenue beat(4)1.11%
Max Revenue beat(4)6.86%
Revenue beat(8)7
Avg Revenue beat(8)2.28%
Revenue beat(12)7
Avg Revenue beat(12)0.98%
Revenue beat(16)7
Avg Revenue beat(16)0.19%
PT rev (1m)0%
PT rev (3m)-1.07%
EPS NQ rev (1m)5.66%
EPS NQ rev (3m)14.75%
EPS NY rev (1m)24.96%
EPS NY rev (3m)38.62%
Revenue NQ rev (1m)1.24%
Revenue NQ rev (3m)4.91%
Revenue NY rev (1m)3.73%
Revenue NY rev (3m)3.98%
Valuation
Industry RankSector Rank
PE 21.76
Fwd PE 13.1
P/S 1.11
P/FCF 12.96
P/OCF 8.14
P/B 1.5
P/tB 1.5
EV/EBITDA 9.31
EPS(TTM)0.95
EY4.6%
EPS(NY)1.58
Fwd EY7.63%
FCF(TTM)1.6
FCFY7.72%
OCF(TTM)2.54
OCFY12.29%
SpS18.66
BVpS13.8
TBVpS13.76
PEG (NY)0.24
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.39%
ROE 7.04%
ROCE 7.5%
ROIC 5.45%
ROICexc 5.72%
ROICexgc 5.73%
OM 10.39%
PM (TTM) 5.21%
GM 24.7%
FCFM 8.55%
ROA(3y)2.77%
ROA(5y)1.65%
ROE(3y)5.91%
ROE(5y)3.57%
ROIC(3y)4.72%
ROIC(5y)4.97%
ROICexc(3y)4.95%
ROICexc(5y)5.26%
ROICexgc(3y)4.97%
ROICexgc(5y)5.28%
ROCE(3y)6.5%
ROCE(5y)6.83%
ROICexcg growth 3Y-6%
ROICexcg growth 5Y-3.21%
ROICexc growth 3Y-5.99%
ROICexc growth 5Y-2.92%
OM growth 3Y-11.18%
OM growth 5Y-7.87%
PM growth 3YN/A
PM growth 5Y-18.12%
GM growth 3Y-5.42%
GM growth 5Y-3.25%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 5.98
Debt/EBITDA 3.02
Cap/Depr 80.43%
Cap/Sales 5.06%
Interest Coverage 2.77
Cash Conversion 81.6%
Profit Quality 164.18%
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 1.7
F-Score8
WACC8.36%
ROIC/WACC0.65
Cap/Depr(3y)58.14%
Cap/Depr(5y)58%
Cap/Sales(3y)3.91%
Cap/Sales(5y)4.1%
Profit Quality(3y)195.22%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.33%
EPS 3Y25.31%
EPS 5Y-17.17%
EPS Q2Q%111.76%
EPS Next Y92.07%
EPS Next 2Y60.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.62%
Revenue growth 3Y1.74%
Revenue growth 5Y-0.19%
Sales Q2Q%9.81%
Revenue Next Year9%
Revenue Next 2Y10.41%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.68%
EBIT growth 3Y-9.64%
EBIT growth 5Y-8.05%
EBIT Next Year91.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.59%
FCF growth 3Y2.78%
FCF growth 5Y4.21%
OCF growth 1Y46.88%
OCF growth 3Y0.74%
OCF growth 5Y-5.35%